59results about How to "Reduce one" patented technology

An aircraft is decelerated by applying a braking force to a wheel of the aircraft as it moves along the ground. An anti skid controller calculates the braking force to be applied by taking into account data relating to the vertical load transmitted between the ground and the wheel and data relating to the slip between the ground and the wheel. Predictions (box 13b) made regarding how the vertical load will change and data (box 13a) concerning the relationship between slip and the ground to wheel friction coefficient are both taken into account when calculating the braking force to be applied. Skids may thereby be predicted in advance and may be reduced or even avoided.

A brake assembly includes a caliper having a first side portion connected to a second side portion by two circumferentially spaced bridge arms. The brake assembly includes a first brake pad and a second brake pad that are interchangeable and each having first and second circumferential ends. Each of the first and second brake pads have a pad formation remote from the first and second circumferential ends. The first brake pad is fitted in the first side portion of the caliper with the pad formation of the first brake pad engaging a caliper formation of the first portion side of the caliper for transferring braking torque loads from the first brake pad to the first side portion of the caliper. The second brake pad is fitted in the second side portion of the caliper with the first and second circumferential ends of the second brake pad engaging respective first and second circumferentially spaced abutments of the brake assembly for transferring braking torque loads from the second brake pad to the brake assembly.

A flat panel display has an optically-transparent electrically-conductive layer, especially an indium tin oxide layer, directly formed on an outer front surface of a liquid crystal display (LCD) assembly having a front plate, a rear plate, and a layer of liquid crystal material interposed between said front and rear plates. The optically-transparent electrically-conductive layer is preferably uniform and functions as an integral heater when connected to a direct current power source.

The load on an aircraft component is measured. In one embodiment, the system is a contactless, all-weather displacement measuring system including a processing unit and a plurality of pairs of controllable microwave emitters and microwave detectors. When the aircraft component is subjected to a load, relative movement of the emitter and detector is caused. The detector generates signals which convey information concerning the relative positions of the emitter and the detector of the pair, the signals being received and processed by a signal processor of the processing unit. The processing unit may, for example with the use of triangulation techniques, provide an output signal representative of the load sustained by the aircraft component. The system may be used to control braking in dependence on the output signal so as to maximise braking efficiency without overloading the landing gear leg.

A floating disc brake assembly comprises a hub and a rotor in mating alignment therewith through one or more interlocking lobes that are alternatingly arranged about an outer peripheral edge of the hub and an internal edge of the rotor. The rotor is coupled to, and disposed circumferentially around, the hub. As a friction element is applied to the rotor to decrease rotation thereof during a braking operation, the interlocking lobes transmit brake torque from the rotor to the hub through a gap existing therebetween. The gap retards heat flow. The gap also permits radial float. Differing hub and rotor widths, or a floating clearance between a fastener and the hub, both permit axial float. Warpage and knockback of the rotor are reduced.

The present disclosure relates to an organic light emitting diode including an emitting material layer that has a host and two different delayed fluorescent materials whose energy levels are controlled and an organic light emitting device including the diode. Exciton energy is transferred from a first delayed fluorescent dopant to a second delayed fluorescent dopant, which has singlet and triplet energy levels lower than singlet and triplet energy levels of the first delayed fluorescent dopant and a narrow FWHM (full-width at half maximum) compared to the first delayed fluorescent dopant so that efficient light emission can be realized.

An organic light emitting diode including a plurality delayed fluorescent materials with specific energy levels and an organic light emitting device including the diode is disclosed. When the plurality delayed fluorescent materials with specific energy levels are applied in an emitting material layer, it is possible to minimize the energy loss or exciton quenching during luminous process and to prevent the diode from reducing life span caused by the exciton quenching. When the emitting material layer includes other luminous material having a narrow FWHM, the organic light emitting diode can enhance its color purity.

The present invention relates to methods of treating or preventing addiction and relapse use of addictive agents, and treating or preventing addictive or compulsive behaviour and relapse practice of an addictive behaviour or compulsion, by administering a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, alone or in combination with another therapeutic agent, such as, for example, an opioid receptor antagonist or an antidepressant, or an addictive agent, such as, for example, an opioid agonist. The present invention also includes pharmaceutical compositions for treating or preventing addiction or relapse that include a PPARγ agonist and one or more other therapeutic or addictive agents, as well as unit dosage forms of such pharmaceutical compositions, which contain a dosage effective in treating or preventing addiction or relapse. The methods and compositions of the invention are useful in the treatment or prevention of addiction to any agent, including alcohol, nicotine, marijuana, cocaine, and amphetamines, as well as compulsive and addictive behaviours, including pathological gambling and pathological overeating.

A method of operating a fuel injector having a piezoelectric actuator for controlling movement of an injector valve needle comprises: (a) prior to an initial fuel injection event, reducing the voltage across the actuator at an initial rate so as to de-energize the actuator; (b) increasing the voltage across the actuator at a first rate in order to initiate an initial fuel injection event of a first fuel injection sequence; and (c) reducing the voltage across the actuator at a second rate in order to terminate the initial fuel injection event. The method may further comprise the step of: (d) increasing the voltage across the actuator at a third rate, which is lower than the first rate, so as to de-energize the actuator but without initiating an injection event, once the initial fuel injection event has terminated and before a subsequent fuel injection event is initiated. The method can be employed particularly to improve actuator lifespan, operating efficiency and / or performance in an energize to inject fuel injector.

The invention discloses a shifting fork lining press-in tool. The shifting fork lining press-in tool comprises a base (4) installed on a press working table, a positioning column (3) and a downwards-pressing column (1), and the positioning column (3) and the downwards-pressing column (1) are fixed to the base (4); the cross section of the positioning column (3) is in a step shape, and the positioning column (3) comprises an upper section, a middle section and a lower section with gradually-increased cross sections, wherein the diameter of the upper section is smaller than the inner diameter of linings, and the diameter of the middle section is larger than the inner diameter of the linings; the shifting fork lining press-in tool further comprises a guide column (2) located between the positioning column (3) and the downwards-pressing column (1), the guide column (2) comprises an upper section, a middle section and a lower section with gradually-decreased cross sections, wherein the diameter of the lower section is smaller than the inner diameter of the linings, and the diameter of the middle section is larger than the inner diameter of the linings; and the axis lines of the downwards-pressing column (1), the guide column (2) and the positioning column (3) are coincident. According to the shifting fork lining press-in tool, the guide column is arranged between the downwards-pressing column and the positioning column, and the upper lining and the lower lining are synchronously pressed into shifting fork shaft holes.

The invention provides methods and compositions for the prevention and treatment of Siglec-8 associated diseases such as chronic rhino sinusitis with concomitant asthma and aspirin-exacerbated respiratory disease. In particular, the invention provides methods for the prevention and treatment of Siglec-8 associated diseases through administration of antibodies or agonists that bind to human Siglec-8 or compositions comprising said antibodies or agonists. The invention also provides articles of manufacture or kits comprising antibodies or agonists that bind to human Siglec-8 for the prevention and treatment of Siglec-8 associated diseases such as chronic rhinosinusitis with concomitant asthma and aspirin-exacerbated respiratory disease.

The present invention relates to methods of treating or preventing addiction and relapse use of addictive agents, and treating or preventing addictive or compulsive behaviour and relapse practice of an addictive behaviour or compulsion, by administering a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, alone or in combination with another therapeutic agent, such as, for example, an opioid receptor antagonist or an antidepressant, or an addictive agent, such as, for example, an opioid agonist. The present invention also includes pharmaceutical compositions for treating or preventing addiction or relapse that include a PPARγ agonist and one or more other therapeutic or addictive agents, as well as unit dosage forms of such pharmaceutical compositions, which contain a dosage effective in treating or preventing addiction or relapse. The methods and compositions of the invention are useful in the treatment or prevention of addiction to any agent, including alcohol, nicotine, marijuana, cocaine, and amphetamines, as well as compulsive and addictive behaviours, including pathological gambling and pathological overeating.